LISATA THERAPEUTICS, INC. (LSTA) Return on equity 2015–2024
LISATA THERAPEUTICS, INC. (LSTA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-111.7%FY2024 · since FY2015: -668.7% → -111.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -111.7% | -44.1 pp |
| FY2023 | -67.6% | -24.3 pp |
| FY2022 | -43.3% | +38.2 pp |
| FY2021 | -81.4% | — |
| FY2015 | -668.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice